Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trials
Phase II clinical trial in neuropathic pain begins
March 16th, 2006
DOV Pharmaceutical, Inc., (DOVP) announced that it has initiated dosing in a phase II clinical trial of bicifadine, an analgesic, in patients with painful diabetic peripheral neuropathy. This is the first study of bicifadine in patients with neuropathic pain. The trial is a randomized, multiple-dose, open-label, 2-phase overlap trial designed to assess the efficacy and safety of bicifadine and potential interactions of bicifadine and oxycodone used concurrently. DOV expects to complete dosing in the third quarter of this year. The clinical trial will randomize 50 patients with painful diabetic neuropathy into 2 parallel 4-week treatment groups. In...
Source: Women's Health Weekly (2006-03-16)
|
